Business Segment Information - Schedule of Revenue, Operating Income and Total Assets by Reportable Segment (Details)		3 Months Ended		9 Months Ended
		Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) Segment	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)
Business segment information
Number of reportable segments | Segment				3
Total revenue		$ 638,900,000	$ 608,900,000	$ 1,822,300,000	$ 1,734,400,000
Operating Income (loss)		131,300,000	113,200,000	301,700,000	287,900,000
Assets		3,336,900,000		3,336,900,000		$ 3,650,000,000.0
Operating segments
Business segment information
Assets		3,254,000,000.0		3,254,000,000.0		3,560,500,000
Eliminations
Business segment information
Total revenue	[1]	(2,700,000)	(3,700,000)	(10,000,000.0)	(10,500,000)
Corporate, eliminations and other
Business segment information
Operating Income (loss)	[2]	(16,400,000)	(16,900,000)	(52,200,000)	(48,900,000)
Assets	[3]	(6,100,000)		(6,100,000)		(8,400,000)
BSI Life Science | Operating segments
Business segment information
Total revenue		383,200,000	380,700,000	1,094,300,000	1,074,300,000
Operating Income (loss)		104,200,000	100,900,000	260,300,000	263,400,000
BSI Nano | Operating segments
Business segment information
Total revenue		199,100,000	174,900,000	559,800,000	504,600,000
Operating Income (loss)		35,300,000	21,800,000	72,200,000	55,100,000
BEST | Operating segments
Business segment information
Total revenue		59,300,000	57,000,000.0	178,200,000	166,000,000.0
Operating Income (loss)		8,200,000	$ 7,400,000	21,400,000	$ 18,300,000
Assets		$ 89,000,000.0		$ 89,000,000.0		$ 97,900,000

[1] Represents product and service revenue between reportable segments.

[2] Represents corporate costs and eliminations not allocated to the reportable segments.

[3] Assets not allocated to the reportable segments and eliminations of intercompany transactions.